Articles with "hepatitis antigen" as a keyword



Molecular evaluation of oral immunogenicity of hepatitis B antigen delivered by hydrogel microparticles.

Sign Up to like & get
recommendations!
Published in 2019 at "Molecular pharmaceutics"

DOI: 10.1021/acs.molpharmaceut.9b00483

Abstract: The development of oral vaccine formulation is crucial to facilitate an effective mass immunization program for various vaccine-preventable diseases. In this work, the efficacy of hepatitis B antigen delivered by bacterial nanocellulose/poly(acrylic acid) composite hydrogel… read more here.

Keywords: hydrogel; hepatitis; hepatitis antigen; antigen ... See more keywords

Predicting hepatitis B e Antigen seroconversion after pregnancy—The SydPregScore

Sign Up to like & get
recommendations!
Published in 2022 at "Liver International"

DOI: 10.1111/liv.15372

Abstract: Achieving Hepatitis B e antigen seroconversion (HBeAg SC) at an earlier age confers a better prognosis. We examined baseline and post‐partum factors associated with HBeAg SC after pregnancy. We developed a tool, the SydPregScore, to… read more here.

Keywords: hepatitis antigen; pregnancy; antigen seroconversion;

HBV Relapse after Discontiniuation of Tenofovir Alafenamide or Entecavir in Non-Cirrhotic Hepatitis B e Antigen-Negative Patients

Sign Up to like & get
recommendations!
Published in 2025 at "Digestive Diseases"

DOI: 10.1159/000544870

Abstract: Abstract Introduction: This study investigated the off-therapy relapse in hepatitis B e antigen (HBeAg)-negative non-cirrhotic patients who discontinued tenofovir alafenamide (TAF) or entecavir (ETV). Methods: Non-cirrhotic HBeAg-negative patients who discontinued TAF or ETV were enrolled.… read more here.

Keywords: hepatitis antigen; relapse; patients discontinued; clinical relapse ... See more keywords

Early Treatment Consideration in Patients with Hepatitis B ‘e’ Antigen-Positive Chronic Infection: Is It Time for a Paradigm Shift?

Sign Up to like & get
recommendations!
Published in 2022 at "Viruses"

DOI: 10.3390/v14050900

Abstract: Chronic hepatitis B (CHB) is associated with significant morbidity and mortality, due to the adverse sequelae of cirrhosis and hepatocellular carcinoma (HCC). To date, antiviral therapy has been reserved for patients with ostensibly active liver… read more here.

Keywords: hepatitis antigen; positive chronic; patients hepatitis; chronic infection ... See more keywords